Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,620.00
-510.00 (-5.59%)
Last updated: Jun 8, 2026, 1:28 PM KST
Market Cap473.05B +20.6%
Revenue (ttm)233.80B +5.1%
Net Income10.10B
EPS194.69
Shares Out 50.70M
PE Ratio46.90
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume101,049
Open7,900.00
Previous Close9,130.00
Day's Range7,900.00 - 8,860.00
52-Week Range7,900.00 - 20,500.00
Beta1.15
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Dialog Axiata

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 809
Stock Exchange Korea Stock Exchange
Ticker Symbol 019170
Full Company Profile

Financial Performance

Financial Statements